Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells-Reference-Cited by-同舟云学术

Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells

Published:2015-01 Issue: Volume:56 Page:66-80
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Bell Charles J.M.,Sun Yongliang,Nowak Urszula M.,Clark Jan,Howlett Sarah,Pekalski Marcin L.^ORCID,Yang Xin,Ast Oliver,Waldhauer Inja,Freimoser-Grundschober Anne,Moessner Ekkehard,Umana Pablo,Klein Christian,Hosse Ralf J.,Wicker Linda S.^ORCID,Peterson Laurence B.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. FOXP3+ regulatory T cells in the human immune system;Sakaguchi;Nat Rev Immunol,2010

2. Regulatory T cells: how do they suppress immune responses?;Sakaguchi;Int Immunol,2009

3. Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells;Chen;Int Immunopharmacol,2011

4. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans;Jeker;Cold Spring Harb Perspect Med,2012

5. FOXP3 and scurfy: how it all began;Ramsdell;Nat Rev Immunol,2014

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression;Frontiers in Immunology;2024-04-18

2. Low-Dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?;Transplantation;2024-01-23

3. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease;Journal of Autoimmunity;2023-11

4. Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-11

5. Multivalent, asymmetric IL-2–Fc fusions show enhanced selectivity for regulatory T cells;Science Signaling;2023-10-17